Improving CSF biomarkers’ performance for predicting progression from Mild Cognitive Impairment to Alzheimer’s disease: a meta-analysis
Background: CSF biomarkers’ performance for predicting conversion from mild cognitive impairment (MCI) to Alzheimer disease (AD) is still suboptimal. Objective: By considering several confounding factors we aimed to identify in which situations these CSF biomarkers can be useful. Data sources: A sys...
Main Authors: | Daniel eFerreira, Amado eRivero-Santana, Lilisbeth ePerestelo-Perez, Eric eWestman, Lars-Olof eWahlund, Antonio eSarria-Santamera, Pedro Guillermo Serrano-Aguilar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-10-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00287/full |
Similar Items
-
Meta-Review of CSF core biomarkers in Alzheimer’s disease: the state-of-the-art after the new revised diagnostic criteria
by: Daniel eFerreira, et al.
Published: (2014-03-01) -
Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers
by: Ramune Grambaite, et al.
Published: (2013-09-01) -
T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease
by: Mohammad Haris, et al.
Published: (2015-01-01) -
Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF
by: Hong-Wei Sun, et al.
Published: (2021-02-01) -
Expression of recombinant G-CSF receptor domains and their inhibitory role on G-CSF function
by: Hamid Bakherad, et al.
Published: (2020-01-01)